Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021

Overview of attention for article published in MMWR: Morbidity & Mortality Weekly Report, January 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

So far, Altmetric has seen 4 public wall posts from 4 users.

A new CDC study finds that before Omicron began circulating, 3 doses of a COVID-19 mRNA vaccine (Pfizer-BioNTech or Moderna…

A new CDC study finds that before Omicron began circulating, 3 doses of a COVID-19 mRNA vaccine (Pfizer-BioNTech or Moderna…

A new MMWR finds that prior to the emergence of Omicron, 3 doses of a COVID-19 mRNA (Pfizer-BioNTech or Moderna) vaccine were…

A new CDC study finds that before Omicron began circulating, 3 doses of a COVID-19 mRNA vaccine (Pfizer-BioNTech or Moderna…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.